Peter Blumencranz

6.1k total citations · 3 hit papers
38 papers, 4.0k citations indexed

About

Peter Blumencranz is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Blumencranz has authored 38 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 18 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Blumencranz's work include Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (14 papers) and Cancer Genomics and Diagnostics (8 papers). Peter Blumencranz is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (14 papers) and Cancer Genomics and Diagnostics (8 papers). Peter Blumencranz collaborates with scholars based in United States, Switzerland and India. Peter Blumencranz's co-authors include Armando E. Giuliano, Linda McCall, Kelly K. Hunt, Peter D. Beitsch, A. Marilyn Leitch, Pat W. Whitworth, Sukamal Saha, Karla V. Ballman, Monica Morrow and Douglas S. Reintgen and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Peter Blumencranz

32 papers receiving 3.9k citations

Hit Papers

Effect of Axillary Dissection vs No Axil... 2007 2026 2013 2019 2017 2010 2007 250 500 750 1000

Peers

Peter Blumencranz
Abigail S. Caudle United States
Sukamal Saha United States
Huong T. Le‐Petross United States
Parvis Gamagami Switzerland
Douglas W. Arthur United States
Barbara Fowble United States
David Poller United Kingdom
Anthony Abner United States
Lorraine Tafra United States
M Mravunac Netherlands
Abigail S. Caudle United States
Peter Blumencranz
Citations per year, relative to Peter Blumencranz Peter Blumencranz (= 1×) peers Abigail S. Caudle

Countries citing papers authored by Peter Blumencranz

Since Specialization
Citations

This map shows the geographic impact of Peter Blumencranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Blumencranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Blumencranz more than expected).

Fields of papers citing papers by Peter Blumencranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Blumencranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Blumencranz. The network helps show where Peter Blumencranz may publish in the future.

Co-authorship network of co-authors of Peter Blumencranz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Blumencranz. A scholar is included among the top collaborators of Peter Blumencranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Blumencranz. Peter Blumencranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wapnir, Irene, E. Shelley Hwang, Kelly K. Hunt, et al.. (2024). Abstract PO5-22-09: Positive pegulicianine fluorescence rate in the lumpectomy cavity correlates with tumor distance to margins in excised tissue. Cancer Research. 84(9_Supplement). PO5–22. 1 indexed citations
3.
Mills, Matthew N., et al.. (2021). Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy. The Oncologist. 26(11). e1931–e1938. 6 indexed citations
4.
Mills, Matthew N., et al.. (2020). Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion. Brachytherapy. 20(2). 345–352. 1 indexed citations
5.
Mills, Matthew N., Casey Liveringhouse, Ronica H. Nanda, et al.. (2020). The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes. Journal of Geriatric Oncology. 12(2). 219–226. 2 indexed citations
6.
Ahmed, Kamran A., Casey Liveringhouse, Matthew N. Mills, et al.. (2019). Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management. EBioMedicine. 47. 163–169. 39 indexed citations
7.
Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2017). Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA. 318(10). 918–918. 1080 indexed citations breakdown →
8.
Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2016). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 264(3). 413–420. 336 indexed citations
9.
Blumencranz, Peter, et al.. (2014). Use of Hydrogel Breast Biopsy Tissue Markers Reduces the Need for Wire Localization. Annals of Surgical Oncology. 21(10). 3273–3277. 19 indexed citations
10.
Blumencranz, Peter, et al.. (2011). Molecular Analysis of Breast Sentinel Lymph Nodes. Surgical Oncology Clinics of North America. 20(3). 467–485. 4 indexed citations
11.
Giuliano, Armando E., Debra Hawes, Karla V. Ballman, et al.. (2011). Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer. JAMA. 306(4). 385–385. 178 indexed citations
12.
Giuliano, Armando E., Linda McCall, Peter D. Beitsch, et al.. (2010). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 252(3). 426–433. 879 indexed citations breakdown →
13.
Silverstein, Melvin J., Abram Recht, Michael D. Lagios, et al.. (2009). Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment. Journal of the American College of Surgeons. 209(4). 504–520. 107 indexed citations
14.
Chagpar, Anees B., Peter Blumencranz, Patrick Whitworth, et al.. (2009). Use Pre- and Intra-Operative Data To Predict Probability of Positive Non-Sentinel Lymph Nodes.. Cancer Research. 69(24_Supplement). 302–302. 4 indexed citations
15.
Blumencranz, Peter, Pat W. Whitworth, Kenneth Deck, et al.. (2007). Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. The American Journal of Surgery. 194(4). 426–432. 67 indexed citations
16.
Posther, Katherine E., Linda McCall, Peter Blumencranz, et al.. (2005). Sentinel Node Skills Verification and Surgeon Performance. Annals of Surgery. 242(4). 593–602. 71 indexed citations
17.
Shivers, Steven C., Charles Cox, George S. Leight, et al.. (2002). Final results of the department of defense multicenter breast lymphatic mapping trial. Annals of Surgical Oncology. 9(3). 248–255. 52 indexed citations
18.
Dupont, Elisabeth, Vidyulata Kamath, Steven C. Shivers, et al.. (2001). The Role of Lymphoscintigraphy in the Management of the Patient With Breast Cancer. Annals of Surgical Oncology. 8(4). 354–60. 29 indexed citations
19.
Hoos, Axel, Mariana Berho, Peter Blumencranz, & Mary S. Brady. (2000). Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: A case report. Journal of Surgical Oncology. 74(4). 278–281. 8 indexed citations
20.
Hoos, Axel, Mariana Berho, Peter Blumencranz, & Mary S. Brady. (2000). Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: A case report. Journal of Surgical Oncology. 74(4). 278–281. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026